Answers are grounded in this paper and cite their sources.
Demonstrates how the CDK5-p25 peptide inhibitor shows dynamic characteristics, suggesting new therapeutic strategies.
< 0.35 kcal/mol) enable rapid nanosecond-time scale interconversion, and multiple structural metrics are consistent with p5 exhibiting the hallmarks of an intrinsically disordered peptide in solution. Temperature-dependent free energy profiles confirm that the low-energy conformational basin is robust across a wide temperature range, validating the physiological relevance of the sampled ensemble. The absence of stable helical structure in the unbound state, combined with the peptide's backbone flexibility and transient β-strand propensity, supports a coupled folding-and-binding mechanism upon CDK5 engagement. These findings provide a structural framework for understanding p5's selective inhibition of CDK5-p25 and lay the groundwork for future simulations of p5-CDK5 complexes and the design of optimized therapeutic CDK5 inhibitors.
No takes yet. Share an insight, caveat, or question.
Ramamurthy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: